DK0833661T3 - Lavpatogen, levende PRRS-virusvaccine og fremgangsmåder til fremstilling af denne - Google Patents

Lavpatogen, levende PRRS-virusvaccine og fremgangsmåder til fremstilling af denne

Info

Publication number
DK0833661T3
DK0833661T3 DK96922508T DK96922508T DK0833661T3 DK 0833661 T3 DK0833661 T3 DK 0833661T3 DK 96922508 T DK96922508 T DK 96922508T DK 96922508 T DK96922508 T DK 96922508T DK 0833661 T3 DK0833661 T3 DK 0833661T3
Authority
DK
Denmark
Prior art keywords
aliquot
strain
mem
cells
plaques
Prior art date
Application number
DK96922508T
Other languages
Danish (da)
English (en)
Inventor
Han Soo Joo
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of DK0833661T3 publication Critical patent/DK0833661T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96922508T 1995-06-21 1996-06-19 Lavpatogen, levende PRRS-virusvaccine og fremgangsmåder til fremstilling af denne DK0833661T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/493,265 US5690940A (en) 1995-06-21 1995-06-21 Low pathogencity PRRS live virus vaccines and methods of preparation thereof
PCT/US1996/010595 WO1997000696A1 (en) 1995-06-21 1996-06-19 Low pathogenicity prrs live virus vaccines and methods of preparation thereof

Publications (1)

Publication Number Publication Date
DK0833661T3 true DK0833661T3 (da) 2002-05-06

Family

ID=23959539

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96922508T DK0833661T3 (da) 1995-06-21 1996-06-19 Lavpatogen, levende PRRS-virusvaccine og fremgangsmåder til fremstilling af denne

Country Status (21)

Country Link
US (1) US5690940A (de)
EP (1) EP0833661B1 (de)
JP (1) JP4709094B2 (de)
KR (1) KR100444809B1 (de)
CN (1) CN1126569C (de)
AT (1) ATE215384T1 (de)
AU (1) AU703084B2 (de)
BR (1) BR9608648A (de)
CA (1) CA2225388C (de)
CZ (1) CZ291611B6 (de)
DE (1) DE69620402T2 (de)
DK (1) DK0833661T3 (de)
ES (1) ES2173300T3 (de)
HK (1) HK1016870A1 (de)
HU (1) HU227754B1 (de)
PL (1) PL184231B1 (de)
PT (1) PT833661E (de)
RU (1) RU2192887C2 (de)
SK (1) SK281024B6 (de)
UA (1) UA47433C2 (de)
WO (1) WO1997000696A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587780B2 (de) * 1991-06-06 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits
SK119498A3 (en) * 1996-03-01 1999-07-12 Schering Corp Porcine reproductive and respiratory syndrome vaccine
US5866401A (en) * 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
EP0839912A1 (de) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Ansteckende Klone von RNA-Viren und darauf basierende Impfstoffe und diagnostisches Verfahren
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
WO2000053787A1 (en) * 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
AU754938B2 (en) 1997-05-06 2002-11-28 Boehringer Ingelheim Vetmedica Gmbh PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays
DK1183332T3 (da) * 1999-04-22 2010-09-06 Us Agriculture Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142
SG83740A1 (en) * 1999-08-10 2001-10-16 Inst Of Molecular Agrobiology An attenuated porcine reproductive and respiratory syndrome virus strain and methods of use
BRPI0510928A (pt) * 2004-06-18 2007-11-13 Univ Minnesota identificação de organismos viralmente infectados e vacinados
US7632636B2 (en) * 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
UA95778C2 (ru) 2005-06-24 2011-09-12 Риджентс Оф Зе Юниверсити Оф Миннесота Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения
US7241582B2 (en) * 2005-07-05 2007-07-10 Mj Biologics, Inc. Diagnostic test kits
CN101848995A (zh) * 2007-06-25 2010-09-29 南达科他州立大学 重组的北美1型猪繁殖与呼吸综合征病毒及使用方法
UA106475C2 (uk) * 2008-08-25 2014-09-10 Берингер Ингельхайм Ветмедика, Инк. Спосіб вакцинації свині проти високопатогенного репродуктивно-респіраторного синдрому свиней (hp prrs)
US8725420B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8545855B2 (en) 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8603495B2 (en) 2008-10-31 2013-12-10 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US8793075B2 (en) 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8545857B2 (en) 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for administering compartmentalized frozen particles
US9060926B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8762067B2 (en) 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US9072799B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9050070B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20100111835A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US8731841B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8551505B2 (en) 2008-10-31 2013-10-08 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8731840B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8409376B2 (en) 2008-10-31 2013-04-02 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8721583B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9060934B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9072688B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US20100111857A1 (en) 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US9060931B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8256233B2 (en) * 2008-10-31 2012-09-04 The Invention Science Fund I, Llc Systems, devices, and methods for making or administering frozen particles
US8788212B2 (en) 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US8784385B2 (en) 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Frozen piercing implements and methods for piercing a substrate
US9050317B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050251B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8788211B2 (en) 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US8551506B2 (en) 2008-10-31 2013-10-08 The Invention Science Fund I, Llc Compositions and methods for administering compartmentalized frozen particles
TWI627281B (zh) * 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
US8492454B2 (en) * 2009-10-05 2013-07-23 Creative Nail Design, Inc. Removable color layer for artificial nail coatings and methods therefore
US8541482B2 (en) * 2009-10-05 2013-09-24 Creative Nail Design, Inc. Removable multilayer nail coating system and methods therefore
US8263677B2 (en) 2009-09-08 2012-09-11 Creative Nail Design, Inc. Removable color gel basecoat for artificial nail coatings and methods therefore
WO2012110490A1 (en) 2011-02-17 2012-08-23 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
MY186535A (en) 2011-02-17 2021-07-26 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain
WO2012121704A1 (en) 2011-03-07 2012-09-13 Creative Nail Design, Inc. Compositions and methods for uv-curable cosmetic nail coatings
KR101281361B1 (ko) 2011-07-18 2013-07-02 서울대학교산학협력단 북미형 돼지 생식기 호흡기 증후군 바이러스 예방 백신 조성물 및 이를 포함하는 혼합백신 조성물
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
US9315781B2 (en) 2011-07-29 2016-04-19 Boehringer Ingelheim Vetmedica Gmbh Infectious CDNA clone of european PRRS virus and uses thereof
MX366051B (es) 2012-12-07 2019-06-26 Univ Illinois Composiciones del virus del síndrome reproductor y respiratorio de porcino y sus usos.
EP2968513A2 (de) 2013-03-15 2016-01-20 Boehringer Ingelheim Vetmedica, Inc. Prrs-virus, zusammensetzungen, impfstoff und verfahren zur verwendung
US10279031B2 (en) 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07501049A (ja) * 1991-10-14 1995-02-02 アクゾ・ノベル・エヌ・ベー ブタ生殖・呼吸系症候群ワクチン及び診断方法
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
ES2152304T3 (es) * 1993-02-08 2001-02-01 Bayer Ag Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas.

Also Published As

Publication number Publication date
KR100444809B1 (ko) 2004-11-06
CN1188417A (zh) 1998-07-22
WO1997000696A1 (en) 1997-01-09
JPH11509087A (ja) 1999-08-17
AU6336196A (en) 1997-01-22
PL184231B1 (pl) 2002-09-30
KR19990022848A (ko) 1999-03-25
EP0833661A4 (de) 1998-10-21
BR9608648A (pt) 1999-12-07
CN1126569C (zh) 2003-11-05
CA2225388C (en) 2010-03-23
CA2225388A1 (en) 1997-01-09
JP2006306894A (ja) 2006-11-09
JP4709094B2 (ja) 2011-06-22
RU2192887C2 (ru) 2002-11-20
HU227754B1 (en) 2012-02-28
PL324204A1 (en) 1998-05-11
MX9710149A (es) 1998-07-31
CZ291611B6 (cs) 2003-04-16
JP3954101B2 (ja) 2007-08-08
AU703084B2 (en) 1999-03-18
SK165797A3 (en) 1998-05-06
HUP9903169A3 (en) 2001-06-28
ES2173300T3 (es) 2002-10-16
HK1016870A1 (en) 1999-11-12
ATE215384T1 (de) 2002-04-15
EP0833661A1 (de) 1998-04-08
SK281024B6 (sk) 2000-11-07
UA47433C2 (uk) 2002-07-15
HUP9903169A2 (hu) 2000-01-28
DE69620402T2 (de) 2002-11-07
EP0833661B1 (de) 2002-04-03
DE69620402D1 (de) 2002-05-08
PT833661E (pt) 2002-08-30
CZ412797A3 (cs) 1998-05-13
US5690940A (en) 1997-11-25

Similar Documents

Publication Publication Date Title
DK0833661T3 (da) Lavpatogen, levende PRRS-virusvaccine og fremgangsmåder til fremstilling af denne
RU98101129A (ru) Низкопатогенные живые вакцины вируса prrs и способы их получения
Mardassi et al. A subset of porcine reproductive and respiratory syndrome virus GP3 glycoprotein is released into the culture medium of cells as a non-virion-associated and membrane-free (soluble) form
NZ320802A (en) Purified mannanase from Bacillus amyloliquefaciens
ATE512213T1 (de) Verfahren zur herstellung eines aktiven bestandteils eines arznei- oder diagnosemittels im mdck-zell-suspensionskultur
WO1998055626A2 (en) Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
NO963418L (no) Cyklisk heptapeptid anti-inflammatorisk middel
DK550182A (da) Mikroorganismer af slaegten hyphomicrobium og fremgangsmaade til nedbrydning af methylgruppeholdige forbindelser i vandige oploesninger
Chatterjee et al. Effect of monensin on Mason-Pfizer monkey virus glycoprotein synthesis
MXPA02007198A (es) Atenuacion recombinante de prrsv.
MX9602256A (es) Vacuna contra la enfermedad de marek.
AU5000797A (en) High level of expression of ingap
ATE237340T1 (de) Hochmolekulargewicht extrakte aus convolvulus arvensis (acker-winde)
Brinton et al. Actinomycin D cytotoxicity for mouse peritoneal macrophages and effect on lactate dehydrogenase-elevating virus replication
Strange Stability of β-galactosidase in starved Escherichia coli
RU2220202C1 (ru) Штамм "бд" вируса репродуктивно-респираторного синдрома свиней для изготовления диагностических и вакцинных препаратов
Oie et al. A Continuous in vitro source of Herpesvirus saimiri
KR0153543B1 (ko) 재조합 헤파타이티스 비 표면항원과 이에 대한 백신의 제조공정
John COVID-19: India's endemic phase heralds the beginning of the end of the pandemic.
JP2960322B2 (ja) 豚の生殖器・呼吸器症候群ウイルス産生性細胞およびその作出法
KR920002771A (ko) 돼지콜레라 바이러스의 외피 당단백질을 추출정제하는 방법
JPS5699795A (en) Preparation of polysaccharide
JPH099983A (ja) Ｌ−トリプトファンの製造方法
严亚贤 et al. Comparative Immune Efficacy of Native Inactivated and Attenuated Vaccines for Porcine Reproductive and Respiratory Syndrome Virus over 2 Consecutive Years
KR960010873A (ko) 단백 다당체의 제조방법